Similar articles

• The macrophage, target cell of the synthetic adjuvant muramyl dipeptide.

  Fevrier M, Birrien JL, Leclerc C, Chedid L, Liacopoulos P. Fevrier M, et al. Eur J Immunol. 1978 Aug;8(8):558-62. doi: 10.1002/eji.1830080804. Eur J Immunol. 1978. PMID: 359336
• [Immunomodulating activity of beta-heptylglycoside-muramyldipeptide in vivo].

  Kaliuzhin OV, Zakharova NS, Britsina MV, Zemliakov AE, Kaliuzhin VV. Kaliuzhin OV, et al. Biull Eksp Biol Med. 1999 Nov;128(11):553-4. Biull Eksp Biol Med. 1999. PMID: 10640246 Russian. No abstract available.
• In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.

  Leclerc C, Juy D, Bourgeois E, Chedid L. Leclerc C, et al. Cell Immunol. 1979 Jun;45(1):199-206. doi: 10.1016/0008-8749(79)90377-0. Cell Immunol. 1979. PMID: 313275 No abstract available.
• The cells involved in the modification of the in vitro immune response by Corynebacterium parvum (C. parvum).

  Liacopoulos-Briot M, Lambert F, Halpern B. Liacopoulos-Briot M, et al. Dev Biol Stand. 1977 Apr 13-15;38:215-21. Dev Biol Stand. 1977. PMID: 344096 No abstract available.
• Target cells for the activity of a synthetic adjuvant: muramyl dipeptide.

  Löwy I, Bona C, Chedid L. Löwy I, et al. Cell Immunol. 1977 Mar 1;29(1):195-9. doi: 10.1016/0008-8749(77)90288-x. Cell Immunol. 1977. PMID: 321136 No abstract available.